Bachrodt Amy's Form 4 filing
Maze Therapeutics, Inc. (MAZE) · filed Feb 4, 2026
- Accession no.
- 0002050422-26-000008
- Filed
- Feb 4, 2026
- Trade date
- Feb 2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $230.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bachrodt AmyCIK 0002050422 | Officer (SVP, Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | MOption exerciseAcquired | +4,844 | $10.42 | +$50,474.48 | 17,809 | Direct | |
| Feb 2, 2026 | Common Stock | MOption exerciseAcquired | +156 | $10.42 | +$1,625.52 | 17,965 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −200 | $44.15 | −$8,830 | 17,765 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −4,064 | $46.03 | −$187,065.92 | 13,701 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −736 | $46.63 | −$34,319.68 | 12,965 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | MOption exerciseDisposed | −4,844 | $0.00 | $0 | 3,025 | Direct | |
| Feb 2, 2026 | Common Stock | MOption exerciseDisposed | −156 | $0.00 | $0 | 41,333 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.